Murray Dallan sold SRPT
May 2, 2024 · Form 4 insider transaction
Murray Dallan sold 3,635 shares of Sarepta Therapeutics, Inc. at $140.00 per share, a transaction worth $508.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,635
Price
$140.00
Total value
$508.9K
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 2, 2024
Filing dateMay 6, 2024
Shares owned after18,125
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.